Ignite Creation Date:
2024-05-06 @ 3:02 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02182830
Status:
COMPLETED
Last Update Posted:
2018-07-31
First Post:
2014-07-03
Brief Title:
24 Week Efficacy and Safety Study of Empagliflozin BI 10773 in Hypertensive BlackAfrican American Patients With Type 2 Diabetes Mellitus and Hypertension
Sponsor:
Organization:
Boehringer Ingelheim